Navigation Links
Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference
Date:5/17/2013

Efficacy Of Tiotropium In A
4 Years Study Analyzed
According To New GOLD
ABCD Severity Grading

M. Decramer

Poster Board # 111

Date: Tuesday, May 21
Poster Viewing: 8:15 a.m. - 9:15 a.m. ET
Discussion: 9:15 a.m. - 10:45 a.m. ETGender-Related Differences
In The Expression Of COPD:
A Matched Case-Control
Study

N. Roche

Poster Board # D5

Date: Wednesday, May 22
Poster Viewing: 10:45 a.m. - 12:30 p.m. ETVariations In Mortality Risk
Among COPD Patients In
Clinical Trials: Data From
The UPLIFT Study

P.R. Burgel

Poster Board # D70

Date: Wednesday, May 22
Poster Viewing: 10:45 a.m. - 12:30 p.m. ETAbout Tiotropium
Tiotropium is a long-acting anticholingeric bronchodilator currently being studied as a once-daily treatment in asthma patients who remain symptomatic despite use of maintenance therapy, including inhaled corticosteroids (ICS) and long-acting beta agonists (LABA). Boehringer Ingelheim is developing the drug in a robust Phase 3 clinical trial program, UniTinA-asthma™, to evaluate its potential across a wide range of asthma patients. Despite current treatment options, approximately 40 percent of patients with asthma remain symptomatic. The UniTinA-asthma Phase 3 clinical trial program is designed to help address the unmet needs of appropriate patients who remain symptomatic despite current therapies. 

About Nintedanib
Nintedanib is an investigational small molecule tyrosine kinase inhibitor (TKI) in development by Boehringer Ingelheim for IPF. It targets three growth factors: the vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR) and platelet-derived growth factor receptor (PDGFR). These receptors have been shown to be potentially involved in pathomechanisms of pulmonary fibrosis. By blocking these signaling pathways that are involved in fibrotic processes, it is hypothesized that
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015  Membership in Medicare ... to a Healthcare Business Strategy report released by ... known as Medigap or Med Supp plans, covered ... 2014, a 5.2% increase from 2013. Between 2013 ... by 551,135 covered lives.  Though UnitedHealth was the ...
(Date:5/6/2015)... 2015  LumiThera Inc., a medical device company focused ... ocular disorders and disease, today announced Retired Congressman ... Board to assist in the company,s mission to treat ... was the U.S. Representative for Washington,s ... He is a member of the Democratic Party. His ...
(Date:5/6/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/jskhnb/energy_based ) has announced ... Global Strategic Business Report" report to their offering. ... Canada , Japan , ... and Rest of World. Annual estimates and forecasts are provided ... analysis is provided for these markets. The global ...
Breaking Medicine Technology:Continued Growth in Med Supp Market for 2014 according to Mark Farrah Associates 2Retired Congressman Norman Dicks Joins LumiThera's Advisory Team 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 3
... , ABBOTT PARK, Ill., Nov. 12 Nearly one in ... normal and nearly 34 million have low HDL "good" cholesterol ... HDL and trigs, Abbott has launched two Web sites: ... , "Unhealthy high triglyceride and low HDL levels are factors ...
... a leader in fluorescence in vivo imaging from ... new Cat B 750 FAST(TM) imaging agent for ... and therapeutic response in vivo . Cathepsin B ... target in a range of diseases, including atherosclerosis, oncology, and ...
Cached Medicine Technology:New Web Sites Educate About Triglycerides and HDL Cholesterol 2VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting 2VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting 3
(Date:5/7/2015)... Falls Church, Va. (PRWEB) May 07, 2015 ... operators use foodservice packaging, making it an integral ... Strategic Sourcing Guide provides direction to foodservice ... foodservice packaging. , Foodservice packaging refers to single-use ... restaurants and other establishments that offer prepared foods ...
(Date:5/7/2015)... 07, 2015 Five CHI Health ... Health Bergan Mercy, CHI Health Immanuel and CHI ... in Papillion, Neb.; and CHI Health Mercy in ... achieving high-quality standards of care by the Accreditation ... to best practices in cardiovascular care. The five ...
(Date:5/7/2015)... NY (PRWEB) May 07, 2015 Over a ... tooth. A broken tooth or a failing crown usually means ... the dentist result in more needle pokes to the ... while the new crown is fabricated. In addition, it takes ... more time than necessary. In the dental chair, Dr. Leonard ...
(Date:5/6/2015)... Church, VA (PRWEB) May 07, 2015 ... Impact of NSF/IPEC/ANSI 363-2014, **FDAnews Webinar**, May 27, ... http://www.fdanews.com/NewGMPStandards , Most drugs contain 70-90% ... aids, binding agents or other purposes that facilitate ... globalization of the pharma industry, combined with a ...
(Date:5/6/2015)... 2015 With recent headlines about the kidnapping ... by 6 men from Southern China, it is becoming apparent ... real concern for them. This is especially true for High ... attract unwanted attention through the property they own, the schools ... Fortunately for those individuals, families and companies that are at ...
Breaking Medicine News(10 mins):Health News:First-Ever Sourcing Guide Aids Purchasers of Foodservice Packaging 2Health News:Five CHI Health Facilities in Nebraska, Iowa Recognized for High-Quality Care by Accreditation for Cardiovascular Excellence 2Health News:Five CHI Health Facilities in Nebraska, Iowa Recognized for High-Quality Care by Accreditation for Cardiovascular Excellence 3Health News:Dr. Leonard Umanoff, DDS Uses New CEREC Crowns that Save Time for Dental Patients 2Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 2Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 3Health News:Pacific Prime China Now Offering Kidnapping & Ransom Insurance 2
... farmers have launched a new foundation to benefit farmworkers, ... for three programs related to child care, health care ... For its inaugural projects, the Farmworker Community Support ... Health Services and the Redlands Christian Migrant ...
... 2009 in World Journal of Gastroenterology addresses ... Kingdom of Saudi Arabia investigated, for the first time, ... is synthesized mainly in the liver, during the development ... deficiency is a risk factor and should be viewed ...
... the future of the cosmetic surgery industry. The ... the cosmetic surgery industry, conducted its annual Procedural Survey ... non-invasive laser treatments. , Over the past ... in both males (456%) and females (215%) electing to ...
... for Florida Providers JACKSONVILLE, Fla., March ... information network, announced today an expanded partnership with ... affordable health care to families and individuals. With ... to Molina Healthcare via the Availity secure web ...
... Robbins & Myers, Inc. (NYSE: RBN ) ... its regular cash dividend payment of $0.04 per share. ... to shareholders of record as of April 10, 2009.Robbins ... equipment and systems for critical applications in global energy, ...
... Now for Summer Relief! Woodward Laboratories adds a New ... NS Antifungal Treatment Line; Makes Diagnosing Nail Fungus Convenient ... 35 million Americans have nail fungus, but only 2.5 ... at Woodward Laboratories, a leading hand, foot and skin ...
Cached Medicine News:Health News:Growers Establish Foundation To Help Farmworkers With Child Care, Health Care and Education 2Health News:Growers Establish Foundation To Help Farmworkers With Child Care, Health Care and Education 3Health News:Growers Establish Foundation To Help Farmworkers With Child Care, Health Care and Education 4Health News:Long-term L-carnitine supplementation prevents development of liver cancer 2Health News:Record number of patients seek laser treatments to take lightyears off their faces 2Health News:Availity Expands Partnership with Molina Healthcare 2Health News:Toes With Nail Fungus Will Be Exposed During Upcoming Summer Sandal Months: Prepare Now 2Health News:Toes With Nail Fungus Will Be Exposed During Upcoming Summer Sandal Months: Prepare Now 3
The CryoSurgery console is the control center for CryoCath's surgical probe. It is a modular system made up of a console control unit and a tank dolly system. The system can be used as a unit or in s...
... minimally invasive cryocatheter to treat atrioventricular ... very high level of safety through ... minimal tissue disruption, and minimal risk ... allows physicians to surgically treat cardiac ...
... is a malleable, single-use cryosurgical probe developed ... The probe will ablate cardiac tissue while ... surgical procedure, such as coronary artery bypass ... and/or repair and as part of the ...
... has developed a minimally invasive cryocatheter ... It delivers a very high level ... pinpoint site precision, minimal tissue disruption, ... stenosis., ,Freezor is a flexible, single-use, ...
Medicine Products: